eXoZymes (EXOZ) Revenue & Revenue Breakdown
eXoZymes Revenue Highlights
00
eXoZymes Revenue by Period
eXoZymes Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | - |
eXoZymes generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
eXoZymes Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $137.76K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | - |
eXoZymes generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
eXoZymes Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SRZN | Surrozen | $10.65M | $983.00K |
| ANEB | Anebulo Pharmaceuticals | - | - |
| TLSA | Tiziana Life Sciences | - | - |
| ESLA | Estrella Immunopharma | - | - |
| CGTX | Cognition Therapeutics | - | - |
| EXOZ | eXoZymes | - | - |
| GLSI | Greenwich LifeSciences | - | $3.61K |
| ATOS | Atossa Therapeutics | - | - |
| TVGN | Tevogen Bio | - | - |
| TIL | Instil Bio | - | - |
| ONCY | Oncolytics Biotech | - | - |